[et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”3.22″][et_pb_fullwidth_post_title author=”off” comments=”off” _builder_version=”3.0.89″ text_orientation=”center”][/et_pb_fullwidth_post_title][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22″][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”3.27.4″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”]
Hepatitis C infection is caused by the hepatitis C virus (HCV). About 1.5 of the U.S. population is infected with HCV. The following are most at risk:
- Patients who have been on long-term kidney dialysis
- Healthcare workers or those who have regular contact with blood
- Those who have unprotected sexual contact with a person who has hepatitis C (this is a less common means of infection, but the risk is higher for those who have many sex partners, already have a sexually transmitted disease, or are infected with HIV)
- Someone who has shared a needle with someone who has hepatitis C
- Received a blood transfusion before July 1992
- Received blood, blood products, or solid organs from a donor who has hepatitis C
- Was tattooed or had accupuncture with contaminated instruments (most licensed, commercial tattoo facilities carry a low risk)
- A less common risk is sharing personal items such as toothbrushes and razors with someone who has hepatitis C
- Born to a mother who was infected with HCV, 1 of 20 babies with infected mothers are infected. (Less common than with hepatitis B)
Hepatitis C has an acute and chronic form. Most people who are infected with the virus develop chronic hepatitis C.
If you suffer from Hepatitis C you may be eligible to participate in a clinical trial at JBR Clinical Research. Visit our website to see if you qualify.
JeanBrownResearch is a Salt Lake City based clinical trial research organization, specializing in pain management and diabetic studies, among other types of clinical trials. Follow us on Twitter and Facebook.
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22″][et_pb_row module_class=”social-share-blog” _builder_version=”3.25″][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_image src=”https://www.jbrclinicalresearch.com/wp-content/uploads/2017/12/twitter-share-1.png” align_tablet=”center” align_last_edited=”on|desktop” _builder_version=”3.23″ always_center_on_mobile=”on”][/et_pb_image][et_pb_image src=”https://www.jbrclinicalresearch.com/wp-content/uploads/2017/12/g-share-1.png” align_tablet=”center” align_last_edited=”on|desktop” _builder_version=”3.23″ always_center_on_mobile=”on”][/et_pb_image][et_pb_image src=”https://www.jbrclinicalresearch.com/wp-content/uploads/2017/12/FB-share-1.png” align_tablet=”center” align_last_edited=”on|desktop” _builder_version=”3.23″ always_center_on_mobile=”on”][/et_pb_image][/et_pb_column][/et_pb_row][/et_pb_section]